My Quote Request
6505-01-371-4206
20 Products
PROHANCE
GADOTERIDOL INJECTION,USP
NSN, MFG P/N
6505013714206
NSN
6505-01-371-4206
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GADOTERIDOL INJECTION USP 30ML VIAL 5S
SPECIAL FEATURES: EACH ML CONTAINS 279.3 MG GADOTERIDOL, 0.23 MG CALTERIDOL CALCIUM, 1.21 MG TROMETHAMINE AND WATER FOR INJECTION; 20-ML FILLS IN SINGLE 30 ML VIAL; NON-IONIC CONTRAST MEDIUM FOR MAGNETIC RESONANCE IMAGING (MRI); 5 PER PACKAGE
Related Searches:
NDC00173-0363-01
RANITIDINE INJECTION,USP
NSN, MFG P/N
6505013714331
NSN
6505-01-371-4331
NDC00173-0363-01
RANITIDINE INJECTION,USP
NSN, MFG P/N
6505013714331
NSN
6505-01-371-4331
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE INJECTION USP 25MG/ML 6ML VIAL
III THERAPEUTIC EQUIVALENT: ZANTAC BY GLAXO
PRIMARY CONTAINER CONTENT QUANTITY: 6.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: EQUIVALENT TO 25 MG OF RANITIDINE PER ML;PRESERVED W/PHENOL
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
ZANTAC
RANITIDINE INJECTION,USP
NSN, MFG P/N
6505013714331
NSN
6505-01-371-4331
MFG
GLAXO WELLCOME INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE INJECTION USP 25MG/ML 6ML VIAL
III THERAPEUTIC EQUIVALENT: ZANTAC BY GLAXO
PRIMARY CONTAINER CONTENT QUANTITY: 6.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: EQUIVALENT TO 25 MG OF RANITIDINE PER ML;PRESERVED W/PHENOL
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
ZANTAC INJECTION
RANITIDINE INJECTION,USP
NSN, MFG P/N
6505013714331
NSN
6505-01-371-4331
ZANTAC INJECTION
RANITIDINE INJECTION,USP
NSN, MFG P/N
6505013714331
NSN
6505-01-371-4331
MFG
GLAXO WELLCOME INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE INJECTION USP 25MG/ML 6ML VIAL
III THERAPEUTIC EQUIVALENT: ZANTAC BY GLAXO
PRIMARY CONTAINER CONTENT QUANTITY: 6.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: EQUIVALENT TO 25 MG OF RANITIDINE PER ML;PRESERVED W/PHENOL
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
0205-02
LUBRICANT,SURGICAL
NSN, MFG P/N
6505013714448
NSN
6505-01-371-4448
MFG
NYCOMED US INC. DIV FOUGERA/SAVAGE LABS/PHARMADERM USE CAGE CODE 60910 FOR CATALOGING.
Description
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
SPECIAL FEATURES: 56.7 GRAMS
Related Searches:
F92L294
GLUCOSE TEST SOLUTION
NSN, MFG P/N
6505013714656
NSN
6505-01-371-4656
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 GRAMS GLUCOSE ACTIVE INGREDIENT
FLAVOR: ORANGE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLUCOSE TEST SOLUTION 75GM ORANGE FLAVOR 10FL OZ BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CARBONATED; DISPOSABLE; TWIST OFF CAPS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
TG-30010
GLUCOSE TEST SOLUTION
NSN, MFG P/N
6505013714656
NSN
6505-01-371-4656
MFG
FISHER SCIENTIFIC CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 GRAMS GLUCOSE ACTIVE INGREDIENT
FLAVOR: ORANGE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLUCOSE TEST SOLUTION 75GM ORANGE FLAVOR 10FL OZ BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CARBONATED; DISPOSABLE; TWIST OFF CAPS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
TRU-GLU
GLUCOSE TEST SOLUTION
NSN, MFG P/N
6505013714656
NSN
6505-01-371-4656
MFG
FISHER SCIENTIFIC CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 GRAMS GLUCOSE ACTIVE INGREDIENT
FLAVOR: ORANGE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLUCOSE TEST SOLUTION 75GM ORANGE FLAVOR 10FL OZ BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CARBONATED; DISPOSABLE; TWIST OFF CAPS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
870501
DICYCLOMINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505013715053
NSN
6505-01-371-5053
870501
DICYCLOMINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505013715053
NSN
6505-01-371-5053
MFG
MAJOR CROWN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS DICYCLOMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 250.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BENTYL
Related Searches:
NDC00904-0193-70
DICYCLOMINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505013715053
NSN
6505-01-371-5053
NDC00904-0193-70
DICYCLOMINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505013715053
NSN
6505-01-371-5053
MFG
MAJOR PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS DICYCLOMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 250.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BENTYL
Related Searches:
DEPO-PROVERA
MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505013715203
NSN
6505-01-371-5203
DEPO-PROVERA
MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505013715203
NSN
6505-01-371-5203
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS MEDROXYPROGESTERONE ACETATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP 1ML VIAL 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III THERAPEUTIC EQUIVALENT: DEPO-PROVERA BY UPJOHN
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: USE PREFERRED NSN 6505-01-529-5618
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00009-0746-35
MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505013715203
NSN
6505-01-371-5203
NDC00009-0746-35
MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505013715203
NSN
6505-01-371-5203
MFG
VETERANS HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS MEDROXYPROGESTERONE ACETATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP 1ML VIAL 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III THERAPEUTIC EQUIVALENT: DEPO-PROVERA BY UPJOHN
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: USE PREFERRED NSN 6505-01-529-5618
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
1400-10
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013715862
NSN
6505-01-371-5862
1400-10
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013715862
NSN
6505-01-371-5862
MFG
GOLDLINE LABORATORIES GOVERNMENT SALES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
17243
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013715862
NSN
6505-01-371-5862
17243
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013715862
NSN
6505-01-371-5862
MFG
GOLDLINE LABORATORIES GOVERNMENT SALES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00182-1400-10
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013715862
NSN
6505-01-371-5862
NDC00182-1400-10
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013715862
NSN
6505-01-371-5862
MFG
GOLDLINE LABORATORIES GOVERNMENT SALES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00258-3581-10
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013715862
NSN
6505-01-371-5862
NDC00258-3581-10
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013715862
NSN
6505-01-371-5862
MFG
FOREST PHARMACEUTICALS INC SUB OF FOREST LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
THEO-DUR SA
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013715862
NSN
6505-01-371-5862
THEO-DUR SA
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013715862
NSN
6505-01-371-5862
MFG
GOLDLINE LABORATORIES GOVERNMENT SALES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CLOZARIL
CLOZAPINE TABLETS
NSN, MFG P/N
6505013716401
NSN
6505-01-371-6401
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 100 MG; UNIT DOSE; 100 TABLETS PER PACKAGE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOZAPINE TABLETS 100MG 100S PG
Related Searches:
F93A340
CLOZAPINE TABLETS
NSN, MFG P/N
6505013716401
NSN
6505-01-371-6401
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 100 MG; UNIT DOSE; 100 TABLETS PER PACKAGE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOZAPINE TABLETS 100MG 100S PG
Related Searches:
NDC00078-0127-06
CLOZAPINE TABLETS
NSN, MFG P/N
6505013716401
NSN
6505-01-371-6401
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 100 MG; UNIT DOSE; 100 TABLETS PER PACKAGE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOZAPINE TABLETS 100MG 100S PG